ORCiD
Adam M. Kaye: 0000-0002-7224-3322
Document Type
Article
Publication Title
Anesthesiology and Pain Medicine
ISSN
2228-7523
Volume
11
Issue
3
DOI
10.5812/aapm.117146
Publication Date
6-1-2021
Abstract
The potential for misuse, overdose, and chronic use has led researchers to look for other methods to decrease opioid consumption in patients with acute and chronic pain states. The use of peripheral nerve blocks for surgery has gained increasing popularity as it minimizes peripheral pain signals from the nociceptors of local tissue sustaining trauma and inflammation from surgery. The individualization of peripheral nerve blocks using adjuvant drugs has the potential to improve patient outcomes and reduce chronic pain. The major limitations of peripheral nerve blocks are their limited duration of action and dose-dependent adverse effects. Adjuvant drugs for peripheral nerve blocks show increasing potential as a solution for postoperative and chronic pain with their synergistic effects to increase the duration of action and decrease the required dosage of local anesthetic. N-methyl-d-aspartate (NMDA) receptor antagonists are a viable option for patients with opioid resistance and neuropathic pain due to their affinity to the neurotransmitter glutamate, which is released when patients experience a noxious stimulus. Neostigmine is a cholinesterase inhibitor that exerts its effect by competitively binding at the active site of acetylcholinesterase, which prevents the hydrolysis of acetylcholine and subsequently retaining acetylcholine at the nerve terminal. Epinephrine, also known as adrenaline, can potentially be used as an adjuvant to accelerate and prolong analgesic effects in digital nerve blocks. The theorized role of sodium bicarbonate in local anesthetic preparations is to increase the pH of the anesthetic. The resulting alkaline solution enables the anesthetic to more readily exist in its un-ionized form, which more efficiently crosses lipid membranes of peripheral nerves. However, more research is needed to show the efficacy of these adjuvants for nerve block prolongation as studies have been either mixed or have small sample sizes.
Recommended Citation
Edinoff, A. N.,
Fitz-Gerald, J. S.,
Holland, K. A.,
Reed, J. G.,
Murnane, S. E.,
Minter, S. G.,
Kaye, A. J.,
Cornett, E. M.,
Imani, F.,
Khademi, S. H.,
Kaye, A. M.,
Urman, R. D.,
&
Kaye, A. D.
(2021).
Adjuvant drugs for peripheral nerve blocks: The role of nmda antagonists, neostigmine, epinephrine, and sodium bicarbonate.
Anesthesiology and Pain Medicine, 11(3),
DOI: 10.5812/aapm.117146
https://scholarlycommons.pacific.edu/phs-facarticles/587
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
